Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.49
10.10.21
€5.00
31.12.23
-32.83%
08.05.23

Could be very worthwhile Investment >20% year
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€26.00
05.10.21
-
05.10.22
-10.00%
08.12.21

Probably not worthwhile Investment
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€19.92
28.09.21
-
28.09.22
-6.85%
02.10.21

Could be worthwhile Investment >10% per year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.79
20.09.21
-
20.09.25
-26.16%
03.04.23

Could be worthwhile Investment >10% per year
buy
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€14.20
18.09.21
€40.00
31.12.23
61.97%
16.12.21

Could be very worthwhile Investment >20% year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€9.95
05.08.21
-
05.08.22
23.44%
08.08.21

Could be worthwhile Investment >10% per year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.39
08.07.21
-
08.07.22
13.98%
08.07.22

buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€3.22
11.06.21
€4.00
11.06.22
-69.57%
14.12.21

Could be worthwhile Investment >10% per year
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€9.52
27.05.21
€32.00
27.05.22
-55.61%
28.05.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Very Future proof/growth oriented business model
buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€4.64
01.05.21
€4.50
01.05.22
-30.60%
11.06.21

Could be worthwhile Investment >10% per year
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€13.28
12.03.21
€24.00
12.03.22
-62.26%
12.03.22

Could be very worthwhile Investment >20% year
CRH Medical Corp

Start price
Target price
Perf. (%)
€3.22
08.02.21
€3.00
08.02.22
-0.62%
22.02.21

Good culture
Probably not worthwhile Investment
Little innovation
No uniques
buy
Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€60.55
16.11.20
€105.00
16.11.21
-10.40%
28.11.20

Could be worthwhile Investment >10% per year
Good rating
Differentiated customer and product portfolio
Risky balance sheet
Trillium Therapeutics

Start price
Target price
Perf. (%)
€8.28
07.09.20
-
04.11.21
-21.91%
15.07.21

Could be very worthwhile Investment >20% year
buy
Trillium Therapeutics

Start price
Target price
Perf. (%)
€8.76
22.08.20
-
07.09.20
-5.48%
07.09.20

Could be very worthwhile Investment >20% year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.08
20.05.20
€4.50
04.11.21
56.99%
05.11.21

Could be worthwhile Investment >10% per year
buy
THC Biomed International Inc.

Start price
Target price
Perf. (%)
€0.070
17.04.20
-
04.11.21
-21.43%
14.10.21

buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€7.15
26.03.20
-
04.11.21
10.29%
05.11.21

Could be very worthwhile Investment >20% year
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€5.44
13.03.20
€9.32
24.07.20
-15.48%
24.07.20

buy
Vbi Vaccines Inc

Start price
Target price
Perf. (%)
-
14.11.19
€1.00
24.11.19
-
24.11.19

buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€1.73
03.06.19
€2.35
20.06.19
36.98%
20.06.19

Could be worthwhile Investment >10% per year
buy
Novelion Therapeutics Inc.

Start price
Target price
Perf. (%)
?0.83
27.05.19
€1.17
15.11.19
0.00%
15.11.19

buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€1.81
26.05.19
€2.71
05.07.19
49.91%
05.07.19

Could be worthwhile Investment >10% per year
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€26.94
25.05.19
€40.00
27.07.20
-82.97%
27.07.20

buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.85
08.02.19
€21.00
04.11.21
372.71%
05.11.21